Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome.
作者信息
Nakajima Kei
机构信息
School of Nutrition and Dietetics, Faculty of Health and Social Services, Kanagawa University of Human Services, 1-10-1 Heisei-cho, Yokosuka, Kanagawa 238-8522, Japan.
Graduate School of Health Innovation, Kanagawa University of Human Services, Research Gate Building Tonomachi 2-A, 3-25-10 Tonomachi, Kawasaki, Kanagawa 210-0821, Japan.
出版信息
J Clin Med Res. 2020 May;12(5):273-275. doi: 10.14740/jocmr4187. Epub 2020 May 8.
Abstract
摘要
相似文献
1
Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome.伴有代谢综合征特征的新冠肺炎严重病情。
J Clin Med Res. 2020 May;12(5):273-275. doi: 10.14740/jocmr4187. Epub 2020 May 8.
2
Symptom Management and Supportive Care of Serious COVID-19 Patients and their Families in India.印度重症新冠肺炎患者及其家属的症状管理与支持性护理
Indian J Crit Care Med. 2020 Jun;24(6):435-444. doi: 10.5005/jp-journals-10071-23400.
3
Severity Detection for the Coronavirus Disease 2019 (COVID-19) Patients Using a Machine Learning Model Based on the Blood and Urine Tests.基于血液和尿液检测的机器学习模型对2019冠状病毒病（COVID-19）患者的严重程度检测
Front Cell Dev Biol. 2020 Jul 31;8:683. doi: 10.3389/fcell.2020.00683. eCollection 2020.
4
Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.间充质干细胞及其外泌体在重症新型冠状病毒肺炎（COVID-19）病例中的治疗潜力
Inflamm Regen. 2020 Jun 22;40:14. doi: 10.1186/s41232-020-00121-y. eCollection 2020.
引用本文的文献
1
Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study.墨西哥东北部代谢综合征患者中 COVID-19 疫苗对 SARS-CoV-2 感染、住院和死亡的有效性评估：一项多中心研究
Vaccines (Basel). 2025 Feb 27;13(3):244. doi: 10.3390/vaccines13030244.
2
COVID-19-Related Coagulopathy-Is Transferrin a Missing Link?新型冠状病毒肺炎相关凝血病——转铁蛋白是其中缺失的一环吗？
Diagnostics (Basel). 2020 Jul 30;10(8):539. doi: 10.3390/diagnostics10080539.
本文引用的文献
1
COVID-19, Modern Pandemic: A Systematic Review From Front-Line Health Care Providers' Perspective.新冠疫情，现代大流行：从一线医护人员视角进行的系统综述
J Clin Med Res. 2020 Apr;12(4):215-229. doi: 10.14740/jocmr4142. Epub 2020 Mar 30.
2
Considerations for Obesity, Vitamin D, and Physical Activity Amid the COVID-19 Pandemic.考虑在 COVID-19 大流行期间针对肥胖、维生素 D 和体力活动的注意事项。
Obesity (Silver Spring). 2020 Jul;28(7):1176-1177. doi: 10.1002/oby.22838. Epub 2020 May 21.
3
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.2019冠状病毒病中的糖尿病：患病率、病理生理学、预后及实际考量
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):303-310. doi: 10.1016/j.dsx.2020.04.004. Epub 2020 Apr 9.
4
Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.冠状病毒感染与 2 型糖尿病：具有治疗意义的共同途径。
Endocr Rev. 2020 Jun 1;41(3). doi: 10.1210/endrev/bnaa011.
5
Risk of COVID-19 for patients with obesity.肥胖患者感染新冠病毒的风险。
Obes Rev. 2020 Jun;21(6):e13034. doi: 10.1111/obr.13034. Epub 2020 Apr 13.
6
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.2019冠状病毒病与内分泌疾病。欧洲内分泌学会声明。
Endocrine. 2020 Apr;68(1):2-5. doi: 10.1007/s12020-020-02294-5.
7
COVID-19 and diabetes: Knowledge in progress.新型冠状病毒肺炎与糖尿病：知识在不断更新。
Diabetes Res Clin Pract. 2020 Apr;162:108142. doi: 10.1016/j.diabres.2020.108142. Epub 2020 Apr 9.
8
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.致编辑的信：糖尿病患者中的 COVID-19：增加发病率的风险因素。
Metabolism. 2020 Jul;108:154224. doi: 10.1016/j.metabol.2020.154224. Epub 2020 Apr 7.
9
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）需要有创机械通气患者中肥胖的高患病率。
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199. doi: 10.1002/oby.22831. Epub 2020 Jun 10.
10
Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission.60岁以下患者的肥胖是COVID-19住院治疗的一个风险因素。
Clin Infect Dis. 2020 Jul 28;71(15):896-897. doi: 10.1093/cid/ciaa415.
Zotero 插件